Skip to main content
Unchecking box will stop auto data updates
Cboe BZX Real-Time Last Sale USD
Today's Change
Volume
Price Quote as of

Today's Trading

Day Low 127.93
Day High 129.30
Open:128.50
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

More stories below advertisement

Description
Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women's health fields, nutritional and over-the-counter pharmaceutical products. The company's Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women's health products. Johnson & Johnson is based in New Brunswick, New Jersey.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Zacks Investment Research, including Income Statements, Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

Stock Reports +

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

StockCalc Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Latest Press Releases

Philogen Announces Drug Discovery Collaboration With Johnson & Johnson Innovation
PR Newswire - 43 minutes ago
PR Newswire - CMTX
43 minutes ago
Philogen S.p.A., a privately-owned biotechnology company, today announced through its wholly-owned Swiss subsidiary, Philochem AG, a collaboration agreement with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to discover new small molecule-based therapeutics utilizing Philochem's novel lead-generation technologies. The collaboration was facilitated by Johnson & Johnson Innovation LLC.
Mark Lanier Honored as National Trial Lawyer of the Year
PR Newswire - Tue Jan 22, 2:03PM CST
PR Newswire - CMTX
Tue Jan 22, 2:03PM CST
Members of the invitation-only National Trial Lawyers have selected Mark Lanier as the group's 2018 Trial Lawyer of the Year for plaintiff litigation and have also included him among the 50 Most Influential Lawyers in the U.S.
Gryphon Investors Acquires RoC, Leading Anti-Aging Skincare Brand
PR Newswire - Tue Jan 22, 9:00AM CST
PR Newswire - CMTX
Tue Jan 22, 9:00AM CST
Gryphon Investors ("Gryphon"), a San Francisco-based middle market private equity firm, announced today that it acquired RoC® Skincare ("RoC"), a market-leading anti-aging skincare brand, from Johnson & Johnson Consumer Inc. Terms of the deal were not disclosed. The transaction is Gryphon's second investment in the beauty sector after the firm acquired indie color cosmetics brand Milani Cosmetics in June 2018.
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 121.00 +6.26% increase
on 12/24/18
Period Open:128.09
Price movement based on the high, low and last over the given period.
131.18 -1.99% decrease
on 01/18/19
+0.48 (+0.37%) increase
since 12/21/18
3-Month 121.00 +6.26% increase
on 12/24/18
Period Open:138.93
Price movement based on the high, low and last over the given period.
148.99 -13.71% decrease
on 12/04/18
-10.36 (-7.46%) decrease
since 10/23/18
52-Week 118.62 +8.39% increase
on 05/29/18
Period Open:141.83
Price movement based on the high, low and last over the given period.
148.99 -13.71% decrease
on 12/04/18
-13.26 (-9.35%) decrease
since 01/23/18

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2019.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

More stories below advertisement